Cargando…
Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970191/ https://www.ncbi.nlm.nih.gov/pubmed/31998646 http://dx.doi.org/10.3389/fonc.2019.01490 |
| _version_ | 1783489466906705920 |
|---|---|
| author | Ripoll, Giselle V. Pifano, Marina Garona, Juan Alonso, Daniel F. |
| author_facet | Ripoll, Giselle V. Pifano, Marina Garona, Juan Alonso, Daniel F. |
| author_sort | Ripoll, Giselle V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6970191 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69701912020-01-29 Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer Ripoll, Giselle V. Pifano, Marina Garona, Juan Alonso, Daniel F. Front Oncol Oncology Frontiers Media S.A. 2020-01-10 /pmc/articles/PMC6970191/ /pubmed/31998646 http://dx.doi.org/10.3389/fonc.2019.01490 Text en Copyright © 2020 Ripoll, Pifano, Garona and Alonso. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Ripoll, Giselle V. Pifano, Marina Garona, Juan Alonso, Daniel F. Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer |
| title | Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer |
| title_full | Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer |
| title_fullStr | Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer |
| title_full_unstemmed | Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer |
| title_short | Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer |
| title_sort | commentary: arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970191/ https://www.ncbi.nlm.nih.gov/pubmed/31998646 http://dx.doi.org/10.3389/fonc.2019.01490 |
| work_keys_str_mv | AT ripollgisellev commentaryargininevasopressinreceptor1aisatherapeutictargetforcastrationresistantprostatecancer AT pifanomarina commentaryargininevasopressinreceptor1aisatherapeutictargetforcastrationresistantprostatecancer AT garonajuan commentaryargininevasopressinreceptor1aisatherapeutictargetforcastrationresistantprostatecancer AT alonsodanielf commentaryargininevasopressinreceptor1aisatherapeutictargetforcastrationresistantprostatecancer |